These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 29282036)
1. Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology. Sartorius K; Sartorius B; Kramvis A; Singh E; Turchinovich A; Burwinkel B; Madiba T; Winkler CA BMC Cancer; 2017 Dec; 17(1):894. PubMed ID: 29282036 [TBL] [Abstract][Full Text] [Related]
2. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203 [TBL] [Abstract][Full Text] [Related]
4. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma. Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012 [TBL] [Abstract][Full Text] [Related]
5. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma. Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637 [TBL] [Abstract][Full Text] [Related]
6. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma. Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532 [TBL] [Abstract][Full Text] [Related]
7. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
8. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer. Motawi TM; Sadik NA; Shaker OG; Ghaleb MH Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA signature in hepatocellular carcinoma patients: identification of potential markers. Elhendawy M; Abdul-Baki EA; Abd-Elsalam S; Hagras MM; Zidan AA; Abdel-Naby AY; Watny M; Elkabash IA; Salem ML; Elshanshoury M; Soliman S; Abdou S Mol Biol Rep; 2020 Jul; 47(7):4945-4953. PubMed ID: 32430845 [TBL] [Abstract][Full Text] [Related]
11. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma. Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560 [TBL] [Abstract][Full Text] [Related]
12. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma. Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019 [TBL] [Abstract][Full Text] [Related]
13. Serum miRNA Panel in Egyptian Patients with Chronic Hepatitis C Related Hepatocellular Carcinoma. Khairy A; Hamza I; Shaker O; Yosry A Asian Pac J Cancer Prev; 2016; 17(5):2699-703. PubMed ID: 27268654 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma. Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC). Shehab-Eldeen S; Nada A; Abou-Elela D; El-Naidany S; Arafat E; Omar T Asian Pac J Cancer Prev; 2019 Aug; 20(8):2515-2522. PubMed ID: 31450927 [TBL] [Abstract][Full Text] [Related]
16. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
17. Expression of Plasma hsa-miR122 in HBV-Related Hepatocellular Carcinoma (HCC) in Vietnamese Patients. Quoc NB; Phuong NDN; Ngan TK; Linh NTM; Cuong PH; Chau NNB Microrna; 2018; 7(2):92-99. PubMed ID: 29701140 [TBL] [Abstract][Full Text] [Related]
18. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
19. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041 [TBL] [Abstract][Full Text] [Related]
20. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis. Li G; Shen Q; Li C; Li D; Chen J; He M Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]